Rewarding Good Outcomes: Do the Drug Companies Have It Right?
In 2007 a deal was struck between the British National Health Service (NHS) and drug manufacturer Johnson and Johnson (J&J). NHS had decided not to pay for J&J’s cancer drug, Velcade, so J&J gave NHS a money-back guarantee.